Ally Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.14M Buy
66,000
+55,000
+500% +$4.4M 0.52% 46
2025
Q4
$1.05M Buy
+11,000
New +$1.08M 0.13% 100
2024
Q1
Sell
-29,000
Closed -$1.68M 110
2023
Q4
$1.68M Hold
29,000
0.22% 77
2023
Q3
$1.53M Buy
+29,000
New +$1.52M 0.23% 82
2023
Q2
Sell
-13,000
Closed -$650K 99
2023
Q1
$650K Hold
13,000
0.1% 87
2022
Q4
$602K Hold
13,000
0.09% 99
2022
Q3
$503K Hold
13,000
0.08% 108
2022
Q2
$485K Buy
+13,000
New +$529K 0.07% 113

Other funds holding BSX

Ally Financial's BSX Position: Q1 2026 in Review

Ally Financial increased its Boston Scientific (BSX) stake by 500% in Q1 2026, buying an estimated $4.4M and bringing the position to 66,000 shares worth $4.14M. The position accounts for 0.52% of the portfolio, ranked #46.

Ally Financial first reported a position in BSX in Q2 2022 and has held it in 8 quarters since. 1,666 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Ally Financial held 66,000 shares of Boston Scientific worth $4.14M as of Q1 2026.
  • Ally Financial bought 55,000 Boston Scientific shares in Q1 2026, an estimated $4.4M.
  • Boston Scientific made up 0.52% of Ally Financial's portfolio in Q1 2026, its #46 holding.
  • Ally Financial first reported a position in Boston Scientific in Q2 2022 and has held it in 8 quarters since.
  • 1,666 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Ally Financial's 13F filing for Q1 2026, filed 12 May 2026.